Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jacques Izopet and Chloé Dimeglio.
Jacques Izopet
Connection Strength
14.687
Chloé Dimeglio
  1. Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection. Clin Infect Dis. 2021 10 05; 73(7):1323-1324.
    View in: PubMed
    Score: 0.971
  2. Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2. Clin Infect Dis. 2021 Aug 12.
    View in: PubMed
    Score: 0.961
  3. Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine. Clin Infect Dis. 2021 Jun 22.
    View in: PubMed
    Score: 0.952
  4. One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection. J Infect. 2021 09; 83(3):381-412.
    View in: PubMed
    Score: 0.951
  5. The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics. Sci Rep. 2021 06 15; 11(1):12597.
    View in: PubMed
    Score: 0.951
  6. Influence of age on the spread of SARS-CoV-2 variant B.1.1.7. J Clin Virol. 2021 08; 141:104872.
    View in: PubMed
    Score: 0.948
  7. Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2. Viruses. 2021 05 12; 13(5).
    View in: PubMed
    Score: 0.945
  8. Diagnosis options in patients suffering from COVID-19-like symptoms. J Med Virol. 2021 Jul; 93(7):4076-4077.
    View in: PubMed
    Score: 0.941
  9. Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France. Rev Med Virol. 2021 09; 31(5):1-8.
    View in: PubMed
    Score: 0.934
  10. Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: A modeling study from Toulouse, France. J Infect. 2021 May; 82(5):186-230.
    View in: PubMed
    Score: 0.927
  11. Quantifying the impact of public health protection measures on the spread of SARS-CoV-2. J Infect. 2021 03; 82(3):414-451.
    View in: PubMed
    Score: 0.910
  12. Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France. J Infect. 2021 01; 82(1):e29-e32.
    View in: PubMed
    Score: 0.906
  13. Children are protected against SARS-CoV-2 infection. J Clin Virol. 2020 07; 128:104451.
    View in: PubMed
    Score: 0.883
  14. The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France. J Infect. 2020 Aug; 81(2):318-356.
    View in: PubMed
    Score: 0.879
  15. Hepatitis E Virus Infections among Patients with Acute Febrile Jaundice in Burkina Faso. Viruses. 2019 06 14; 11(6).
    View in: PubMed
    Score: 0.828
  16. Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study. Diagn Microbiol Infect Dis. 2021 Nov; 101(3):115478.
    View in: PubMed
    Score: 0.239
  17. COVID-19 pandemic period, where are the seasonal viruses? J Med Virol. 2021 Jul; 93(7):4097-4098.
    View in: PubMed
    Score: 0.235
  18. Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers. J Clin Virol. 2020 09; 130:104580.
    View in: PubMed
    Score: 0.224
  19. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses. 2019 07 09; 11(7).
    View in: PubMed
    Score: 0.052
  20. Acute hepatitis E in French patients and neurological manifestations. J Infect. 2018 09; 77(3):220-226.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.